SARA GOODWIN: Open Payments
NPI 1013764984 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 17 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $52 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Lilly USA, LLC | 3 | $55 |
| ABBVIE INC. | 2 | $34 |
| Novo Nordisk Inc | 2 | $34 |
| Astellas Pharma US Inc | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Abbott Laboratories | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: SPRAVATO, CAPLYTA, MOUNJARO, VRAYLAR, Wegovy, Veozah, GEMTESA, FREESTYLE LIBRE 3.
Industry payments across IN — which companies pay providers there.
